News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–77
Matches
77
Sources here
4
Companies here
1
Search results Stored financial headlines

Active search

77 matching headlines

Ticker or company: ALNYMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Stock Traders Daily Balance sheet Main company 🇺🇸 United States

Liquidity Mapping Around (ALNY) Price Events

This article provides a quantitative analysis of Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) focusing on liquidity mapping around price events. It highlights near-term weak sentiment, a significant risk-reward setup targeting a 17.9% gain versus 0.3% risk, and outlines three distinct AI-generated trading strategies for different …

ALNY main company
Sharemaestro market context Price below Trend Line 52 weeks -49.7% · Next-week setup negative 43.7% ALNY stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Moomoo Earnings Main company 🇺🇸 United States

Press Release: Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results

Alnylam Pharmaceuticals (Nasdaq: ALNY) announced it will webcast a conference call on July 29, 2026, to discuss its second quarter 2026 financial results and provide a business update. The call will follow the release of its financial results that same day. Interested parties can …

ALNY main company
Sharemaestro market context Price below Trend Line 52 weeks -49.7% · Next-week setup negative 43.7% ALNY stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Trefis Market update Main company 🇺🇸 United States

Alnylam Pharmaceuticals Stock In Shambles: Down 14% With 5-Day Losing Streak

Alnylam Pharmaceuticals (NASDAQ: ALNY) stock has experienced a significant downturn, dropping 14% and marking a five-day losing streak. This indicates a challenging period for the company's market performance.

ALNY main company
Sharemaestro market context Price below Trend Line 52 weeks -49.7% · Next-week setup negative 43.7% ALNY stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Trefis Market update Main company 🇺🇸 United States

Alnylam Pharmaceuticals Stock: 5 Straight Red Days, Down 14%

Alnylam Pharmaceuticals (ALNY) stock has experienced a significant downturn, falling 14% over five consecutive trading days, erasing $5.9 billion from its market value. Despite the biotech firm's impressive 82.6% revenue growth over the last year, its high price-to-earnings multiple of 64.3 suggests a premium …

ALNY main company
Sharemaestro market context Price below Trend Line 52 weeks -49.7% · Next-week setup negative 43.7% ALNY stored weekly price path from 22 Aug 2025 to 14 Aug 2026
BioSpace Market update Main company 🇺🇸 United States

Alnylam Highlights Progress with Neuroscience Programs at AAIC 2026, Showcasing Potential of RNAi in Neurological Disease

Alnylam Pharmaceuticals is advancing its neuroscience pipeline, highlighted at AAIC 2026, with RNAi therapeutics for neurological diseases. Key developments include the initiation of a Phase 2 study for mivelsiran in Down Syndrome-Associated Alzheimer’s Disease and the completion of enrollment for another Phase 2 study …

ALNY main company
Sharemaestro market context Price below Trend Line 52 weeks -49.7% · Next-week setup negative 43.7% ALNY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context